← Companies|Intas Pharma
In

Intas Pharma

Ahmedabad INFounded 198416,000 employees
Private CappharmaPrivateOncologyHematology
Platform: Injectable Bio
Market Cap
N/A
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
INT-6808INT-6808Approved3siRNAEZH2C5iMS
TerafutibatinibINT-7864Phase 31DegraderAuroraAAuroraAiBreast CaUC
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)
2026-09-06
INT-6808 Ph3 Readout
MS
Ph3 Readout
2026-11-15
INT-6808 Ph3 Readout
MS
Ph3 Readout
2027-04-09
INT-6808 Ph3 Readout
MS
Ph3 Readout
2029-05-24
Terafutibatinib Ph3 Readout
UC
Ph3 Readout